日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial

接受强化治疗或克拉屈滨治疗的急性髓系白血病老年患者的生存情况:E2906 III期试验

Foran, James M; Sun, Zhuoxin; Luger, Selina M; Claxton, David F; Lazarus, Hillard M; Arber, Daniel A; Rowe, Jacob M; Paietta, Elisabeth; Racevskis, Janis; Garrett-Bakelman, Fran; Zhang, Yanming; Altman, Jessica K; Al-Kali, Aref; Zheng, Hong; Pratz, Keith W; Broun, E Randolph; Powell, Bayard L; O'Dwyer, Kristen Marie; Godwin, John E; Ofran, Yishai; Litzow, Mark R; Tallman, Martin S

Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia

维奈托克和阿扎胞苷用于未经治疗的治疗相关性急性髓系白血病、既往骨髓增生异常综合征或慢性粒单核细胞白血病患者

Pullarkat, Vinod; Pratz, Keith W; Döhner, Hartmut; Recher, Christian; Thirman, Michael J; DiNardo, Courtney D; Fenaux, Pierre; Schuh, Andre C; Wei, Andrew H; Pigneux, Arnaud; Jang, Jun-Ho; Juliusson, Gunnar; Miyazaki, Yasushi; Selleslag, Dominik; Arellano, Martha L; Liu, Chenglong; Ridgeway, Jean A; Potluri, Jalaja; Schuler, Jovita; Konopleva, Marina

The impact of post-remission granulocyte colony-stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia

在维奈托克联合治疗新诊断急性髓系白血病患者的3期研究中,缓解后粒细胞集落刺激因子的使用影响

DiNardo, Courtney D; Pratz, Keith W; Panayiotidis, Panayiotis; Wei, Xudong; Vorobyev, Vladimir; Illés, Árpád; Kim, Inho; Ivanov, Vladimir; Ku, Grace; Miller, Catherine L; Zhang, Meng; Tatsch, Fernando; Potluri, Jalaja; Schmidt, Xenia; Récher, Christian

Evolving racial/ethnic disparities in AML survival in the novel therapy era

新疗法时代急性髓系白血病生存率中不断演变的种族/民族差异

Wang, Xin; Gimotty, Phyllis A; Matthews, Andrew H; Mamtani, Ronac; Luger, Selina M; Hexner, Elizabeth O; Babushok, Daria V; McCurdy, Shannon R; Frey, Noelle V; Bruno, Ximena Jordan; Gill, Saar; Martin, Mary Ellen; Paralkar, Vikram R; Maillard, Ivan; Porter, David L; Loren, Alison W; Perl, Alexander E; Pratz, Keith W; Getz, Kelly D; Lai, Catherine

Advancing the outcomes of AML out of antecedent MPN by targeting mutated IDH1

通过靶向突变的IDH1,改善AML患者从MPN中康复的预后

Pratz, Keith W

Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

Blinatumomab 用于治疗成人 MRD 阴性急性淋巴细胞白血病

Litzow, Mark R; Sun, Zhuoxin; Mattison, Ryan J; Paietta, Elisabeth M; Roberts, Kathryn G; Zhang, Yanming; Racevskis, Janis; Lazarus, Hillard M; Rowe, Jacob M; Arber, Daniel A; Wieduwilt, Matthew J; Liedtke, Michaela; Bergeron, Julie; Wood, Brent L; Zhao, Yaqi; Wu, Gang; Chang, Ti-Cheng; Zhang, Wenchao; Pratz, Keith W; Dinner, Shira N; Frey, Noelle; Gore, Steven D; Bhatnagar, Bhavana; Atallah, Ehab L; Uy, Geoffrey L; Jeyakumar, Deepa; Lin, Tara L; Willman, Cheryl L; DeAngelo, Daniel J; Patel, Shejal B; Elliott, Michelle A; Advani, Anjali S; Tzachanis, Dimitrios; Vachhani, Pankit; Bhave, Rupali R; Sharon, Elad; Little, Richard F; Erba, Harry P; Stone, Richard M; Luger, Selina M; Mullighan, Charles G; Tallman, Martin S

Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine

维奈托克和阿扎胞苷治疗初治急性髓系白血病患者的遗传风险分层和预后

Döhner, Hartmut; Pratz, Keith W; DiNardo, Courtney D; Wei, Andrew H; Jonas, Brian A; Pullarkat, Vinod A; Thirman, Michael J; Récher, Christian; Schuh, Andre C; Babu, Sunil; Li, Xiaotong; Ku, Grace; Liu, Zihuan; Sun, Yan; Potluri, Jalaja; Dail, Monique; Chyla, Brenda; Pollyea, Daniel A

Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia

去甲基化药物与继发于获得性再生障碍性贫血的继发性髓系肿瘤患者较高的血液毒性发生率相关。

Connor, Matthew P; Prathapa, Neeharika; Frey, Noelle V; Gill, Saar I; Hexner, Elizabeth O; Bruno, Ximena Jordan; Lai, Catherine E; Loren, Alison W; Luger, Selina M; Matthews, Andrew H; McCurdy, Shannon R; Perl, Alexander E; Porter, David L; Zeringue, Arlene; Oved, Joseph H; Olson, Timothy S; Pratz, Keith W; Babushok, Daria V

Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients

预处理后的虚弱表型影响老年同种异体移植受者的生存率和复发率

Sung, Anthony D; Koll, Thuy; Gier, Shannon H; Racioppi, Alessandro; White, Griffin; Lew, Meagan; Free, Marcia; Agarwal, Priyal; Bohannon, Lauren M; Johnson, Ernaya J; Selvan, Bharathi; Babushok, Daria V; Frey, Noelle V; Gill, Saar I; Hexner, Elizabeth O; Martin, MaryEllen; Perl, Alexander E; Pratz, Keith W; Luger, Selina M; Chao, Nelson J; Fisher, Alfred L; Stadtmauer, Edward A; Porter, David L; Loren, Alison W; Bhatt, Vijaya R; Gimotty, Phyllis A; McCurdy, Shannon R

Recent advances in targeted therapies in acute myeloid leukemia

急性髓系白血病靶向治疗的最新进展

Bhansali, Rahul S; Pratz, Keith W; Lai, Catherine